| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2024―Sep―12 |
レセプトデータに基づく外来を含む COVID-19 患者特定アルゴリズムのバリデーション研究：VENUS Study |
卓 近持, 亘 三村, 智恵子 石黒, 恵 前田, 典子 村田, 治久 福田 |
| 2 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2024―Sep―12 |
COVID-19 pandemic: double-edged sword in electronic health records research |
Angel Wong |
| 3 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2023―Oct―19 |
レセプトデータを用いた COVID-19 入院患者特定のためのアルゴリズムのバリデーション研究 |
智恵子 石黒, 亘 三村, 大範 石割, 展明 松永, 純子 寺田, 弘之 星本, et al. (+2) 賢吾 美代, 貴夫 大曲 |
| 4 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2023―Oct―19 |
電子カルテ情報に基づいた 2020 年の coronavirus disease 2019 国内患者の記述疫学：多施設横断研究 |
正人 竹内, 翔一朗 猪口, 丈 木村, 成美 江口, 泰 高橋, 浩司 川上 |
| 5 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2022―Nov―20 |
4 ． Early Post-marketing Phase Vigilance and Post-marketing Survey of SARS-CoV-2 Vaccine Under COVID-19 Situation |
Hiroyuki NAKAMICHI, Yoshinori IKEDA |
| 6 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2022―Nov―20 |
1 ． Distribution Information and Systems as a Basis for Safety Assessment of COVID-19 Vaccine in Japan |
Yoshihiko INAZUMI |
| 7 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2022―Nov―20 |
3 ． Experiences in Safety Measures for COVID-19 Vaccine（ChAdOx1-S ［recombinant］）（Vaxzevria<sup>TM</sup> Intramuscular Injection）： Focusing on the Early Post-marketing Phase Vigilance |
Masako SHIMOO, Hiroko KATO, Toshimitsu TOKIMOTO |
| 8 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2022―Apr―18 |
糖尿病治療における SARS-CoV2 感染率と COVID-19 の重症度に対するリスクの相違 |
康一 白川 |
| 9 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2022―Apr―18 |
慶應義塾大学薬学部における COVID-19 ワクチン職域接種サーベイランス（中間報告） |
佳穂 奥村, 梓 原, 大典 杉山, 崇宏 星野, 高弘 矢向, 裕一 横山, 尚巳 漆原 |
| 10 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2021―Jul―25 |
2．Response to COVID-19 from a Social Welfare Policy Perspective |
Ichiro WADA |
| 11 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2021―Jul―25 |
3．Value Assessment of Vaccines and Drugs： Learnings from COVID-19 Pandemic |
Yasuko AITOKU |
| 12 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2021―Jul―25 |
Joint statement to consolidate the pharmacovigilance systems for securing safety of the COVID-19 vaccine products |
|
| 13 |
[GO] |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku |
2021―Jul―25 |
5．Confronting COVID-19： Current Issues of SARS-CoV-2 Therapeutic Drug/Vaccine Development |
Wataru SUGIURA |
